Combination of <scp>PARP</scp> inhibitor and <scp>CDK4</scp>/6 inhibitor modulates <scp>cGAS</scp>/<scp>STING‐</scp>dependent therapy‐induced senescence and provides “one‐two punch” opportunity with <scp>anti‐PD‐L1</scp> therapy in colorectal cancer
Tao Wang(Union Hospital), Yuping Yin(Wuhan Union Hospital)
Cited by 38
Related Papers
Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects
|Frontiers in Aging Neuroscience|2018|378
Two-Year Outcomes and Biomarker Analysis of Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma After Neoadjuvant Chemotherapy and Immunotherapy from the Phase II WuhanUHGI001 Trial
|Annals of Surgical Oncology|2024|14
MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer
|Frontiers in Oncology|2022|9
Preoperative serum magnesium level as a prognostic and predictive biomarker in locally advanced gastric cancer patients receiving neoadjuvant immunochemotherapy
|World Journal of Surgical Oncology|2025|2